In patients with nonalcoholic fatty liver disease (NAFLD), steatohepatitis (NASH) is a risk factor for development of fibrosis. However, fibrosis has been observed in livers of patients without NASH. We aimed to estimate the prevalence of fibrosis in patients without NASH and risk factors for fibrosis.
Pelusi, S., Cespiati, A., Rametta, R., Pennisi, G., Mannisto, V., Rosso, C., et al. (2019). Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2310-2319 [10.1016/j.cgh.2019.01.027].
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis
Pennisi, G;Craxi, A;Petta, S;Valenti, L
2019-01-01
Abstract
In patients with nonalcoholic fatty liver disease (NAFLD), steatohepatitis (NASH) is a risk factor for development of fibrosis. However, fibrosis has been observed in livers of patients without NASH. We aimed to estimate the prevalence of fibrosis in patients without NASH and risk factors for fibrosis.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1542356519300746-main.pdf
Solo gestori archvio
Tipologia:
Post-print
Dimensione
1.07 MB
Formato
Adobe PDF
|
1.07 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
Prevalence and Risk Factors of Significant Fibrosis in.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
1.02 MB
Formato
Adobe PDF
|
1.02 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
